UT-HTL
HTL , the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc. , a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005119/en/
The partnership provides academic research and pharmaceutical development laboratories’ expanded access to Good Manufacturing Practices (GMP)-grade, kit-packaged hyaluronic acid and glycosaminoglycan (GAG) products. By offering premium, clinical grade products to early-stage research investigators, the partnership seeks to bridge the gap between lab-based research, development and commercialization, and accelerate innovation worldwide.
“Innovation is at the heart of HTL’s DNA,” said HTL CEO Yvon Bastard . “This growth opportunity reinforces our mission and vision to apply science for increased bio-compatibility and improved health outcomes around the world.”
“This new partnership offers scientists and researchers the key technologies to develop innovative biopolymer solutions for new medical applications in aesthetics, ophthalmology, rheumatology, tissue engineering and drug delivery,” said Charles Ruban , HTL deputy CEO. “This is the true meaning of HTL’s tagline of ‘Beyond, together.’ HTL’s ambition is not only to grow its lead position in producing and distributing hyaluronic acid worldwide, but also to build tomorrow’s glycosaminoglycan-based solutions.”
“Echelon has been granted the opportunity to expand its market-leading HA assays and extra cellular matrix product line with the supply of HTL ’s hyaluronic acid and other GAG-derived products. HTL is recognized internationally for producing biopolymers of premium quality,” says Bert Israelsen , president of Echelon Biosciences . “Echelon offers our customers access to the latest innovative tools with unparalleled technical support, thereby fully enabling maximized creativity in basic and applied research. With its fermentation and organic synthesis platforms, HTL creates functionality and added value by developing chemically modified biopolymers tailored to specific needs.”
“This new partnership is a milestone in HTL’s expanding footprint in the North American market and with the U.S. medical community,” said Glenn Prestwich, Ph.D ., one of Echelon’s founders and now HTL’s exclusive science and innovation advisor for this market. By entrusting Echelon with the distribution of HTL’s hyaluronic acid and glycosaminoglycan products for research use, HTL aims to significantly increase its support and involvement in biopolymer research in the U.S. and worldwide, but also its research and development capacity.
“This new initiative demonstrates HTL’s commitment to invest in innovation in healthcare,” said Humberto C. Antunes , strategic advisor to HTL and former CEO of Galderma. “In the fields of health and wellness, the biotechnology ecosystem of innovation, incubators, and established and emerging companies are incredibly dynamic in the United States, Mexico and Canada. It means a huge growth potential for HTL products,” added Antunes.
About HTL
HTL is a biotechnology company, leading the way in the design and production of pharmaceutical grade hyaluronic acid and other innovative functional biopolymers for premium medical products. HTL serves the pharmaceutical and medical device industries worldwide, enabling them to transform lives of patients. HTL’s unsurpassed commitment to client partnership has been consistently proven in the marketplace. The company is recognized for supplying the highest quality products and continually investing in driving and supporting market growth. For over 25 years, its cutting-edge research and development has allowed to develop unique value-driven solutions to meet the innovation needs of its clients.
About Echelon Biosciences, Inc.
Based in Salt Lake City, Utah, Echelon Biosciences, was established in 1997 to supply synthetic lipid reagents for research and development. Since then, Echelon has successfully grown in scale and scope to include custom chemistry, peptides, and biological assays with over 700 catalog items in the fields of cell signaling, extracellular matrix, cancer drug discovery, and disease biomarkers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005119/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NIQ-GfK Wins Radio and TV Measurement Contracts in South Africa15.10.2025 11:00:00 CEST | Press release
Comprehensive audience measurement system sets new standard for the South African media, marketing and advertising industry. NIQ (NYSE: NIQ), a leading consumer intelligence company, is proud to announce that the Broadcast Research Council of South Africa (BRC) has appointed GfK, an NIQ company, to provide comprehensive measurement of radio and television audiences nationwide. This milestone marks a new era for South African media, marketing, and advertising, empowering the industry with robust, innovative, and actionable audience data. Following a rigorous and competitive selection process, the BRC first awarded the Radio Audience Measurement System (RAMS) contract to GfK in June 2025. The first round of radio data collection is already underway and initial insights will be released in Q1 2026. In addition, GfK will also design and deploy South Africa’s new Total Video Measurement service, aligning the country’s TV currency with the way audiences consume content today. Gary Whitaker,
Bentley Systems Advances Infrastructure AI with New Applications and Industry Collaboration15.10.2025 09:53:00 CEST | Press release
Company shares its vision for trustworthy AI to shape the future of infrastructure Bentley Systems’ Year in Infrastructure 2025 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today unveiled new infrastructure AI capabilities at its Year in Infrastructure conference. Bentley also announced an Infrastructure AI co-innovation initiative, inviting engineering firms and asset owners to collaborate on the next generation of AI workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015714746/en/ Bentley's OpenSite+, the first engineering application leveraging generative AI for civil site design, is now in limited availability. It delivers projects up to 10 times faster without sacrificing accuracy. (Image courtesy of Bentley Systems) “AI is poised to transform infrastructure,” said Bentley CEO Nicholas Cumins. “At Bentley, our vision is for AI to empower infrastructure enginee
Bentley Systems Announces Bentley Infrastructure Cloud Connect15.10.2025 09:51:00 CEST | Press release
Provides a trusted foundation to connect data and people across the infrastructure lifecycle and value chain (Bentley Systems’ Year in Infrastructure 2025) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced Bentley Infrastructure Cloud Connect, the new foundational layer of Bentley Infrastructure Cloud. Connect provides a connected data environment and unified experience for infrastructure professionals interacting with project and asset data, improving collaboration across the infrastructure lifecycle and value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015261978/en/ Bentley Systems announced Bentley Infrastructure Cloud Connect, providing a trusted foundation to connect data and people across the infrastructure lifecycle and value chain. (Image courtesy of Bentley Systems) “Infrastructure data lives everywhere—in models, PDFs, inspection forms, phot
Bentley Systems Bolsters Cesium with Reality Modeling Capabilities, Brings Geospatial Context to Infrastructure Engineering15.10.2025 09:50:00 CEST | Press release
Bentley advances its open platform for the built and natural environment (Bentley Systems’ Year in Infrastructure 2025) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the availability of reality modeling services in Cesium, advancing its open platform for the built and natural environment. It also unveiled geospatial capabilities for project delivery and asset performance and a new immersive engagement application for infrastructure teams and stakeholders, all powered by Cesium. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015286327/en/ Bentley announced the availability of reality modeling services in Cesium, advancing its open platform for the built and natural environment. (Image courtesy of Bentley Systems) Since acquiring Cesium a year ago, Bentley has made significant progress in integrating technologies from both companies, powering its own products
SkySparc Acquires Inovotek Solutions to Strengthen Its Capital Markets Expertise and Expand Delivery Across Murex, Calypso, and FIS Platforms15.10.2025 09:00:00 CEST | Press release
SkySparc, a trusted global provider of digital transformation solutions for treasury and finance institutions, today announced the acquisition of Inovotek Solutions (“Inovotek” or the “Company”), a specialist provider of transformation services to capital markets and financial institutions. Financial terms were not disclosed. The acquisition will bolster SkySparc's position as a premier provider of comprehensive digital transformation services to capital markets clients globally. It will address critical client challenges, including regulatory compliance and complex re-platforming initiatives. Additionally, SkySparc will expand its expertise across leading trading and risk management platforms such as Murex, Calypso, and FIS. By combining Inovotek’s program management expertise with SkySparc’s established managed services and proprietary software – OmniFi and Optimizer – the Company will deliver a robust and complete offering capable of addressing the most complex and demanding client
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom